Impaired glycemia increases disease progression in mild cognitive impairment
暂无分享,去创建一个
Eric D. Vidoni | Jeffrey M. Burns | R. Honea | E. Vidoni | J. Burns | Jill K. Morris | Robyn A. Honea | J. Morris
[1] S. Seneff,et al. Association of alzheimer disease pathology with abnormal lipid metabolism: the hisayama study , 2012, Neurology.
[2] G. Lesser. Association of Alzheimer Disease Pathology with Abnormal Lipid Metabolism: The Hisayama Study , 2012, Neurology.
[3] M. Martínez-González,et al. The role of diet in the prevention of type 2 diabetes. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[4] L. Luzi,et al. Lack of association of apoE ε4 allele with insulin resistance , 2012, Acta Diabetologica.
[5] G. Hotamisligil. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. , 2005, Diabetes.
[6] S. Lovestone,et al. Risk of developing dementia in people with diabetes and mild cognitive impairment , 2010, British Journal of Psychiatry.
[7] J. Leahy. Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population: National Health and Nutrition Examination Survey 1999–2002 , 2007 .
[8] J. Duchek,et al. Reliability of the Washington University Clinical Dementia Rating. , 1988, Archives of neurology.
[9] Lars Bäckman,et al. Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes , 2010, Alzheimer's & Dementia.
[10] F. D. De Felice. Alzheimer's disease and insulin resistance: translating basic science into clinical applications. , 2013, The Journal of clinical investigation.
[11] D. A. Bennett,et al. Natural history of mild cognitive impairment in older persons , 2002, Neurology.
[12] Z. Wszolek,et al. VASCULAR RISK FACTORS AND DEMENTIA: HOW TO MOVE FORWARD? , 2009, Neurology.
[13] A. Khera,et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. , 2012, JAMA.
[14] E. Tangalos,et al. CME Practice parameter: , 2022 .
[15] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[16] C. Jonker,et al. The role of lipoproteins and inflammation in cognitive decline: Do they interact? , 2012, Neurobiology of Aging.
[17] Rachel L. Mistur,et al. Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease , 2009, Neurology.
[18] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[19] Cindee M. Madison,et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI , 2011, Neurobiology of Aging.
[20] L. Puglielli,et al. Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. , 2003, The Journal of biological chemistry.
[21] F. D. Felice. Alzheimer’s disease and insulin resistance: translating basic science into clinical applications , 2013 .
[22] J. Thyfault,et al. Type 2 diabetes sits in a chair , 2013, Diabetes, obesity & metabolism.
[23] Meghan B. Mitchell,et al. A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery , 2011, Alzheimer's Research & Therapy.
[24] J. Donnelly,et al. Peripheral insulin and brain structure in early Alzheimer disease , 2007, Neurology.
[25] R. Honea,et al. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease , 2011, Neurology.
[26] A. Dale,et al. High‐resolution intersubject averaging and a coordinate system for the cortical surface , 1999, Human brain mapping.
[27] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[28] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative , 2008 .
[29] L. Puglielli,et al. Withdrawal: Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis , 2003, Journal of Biological Chemistry.
[30] D A Follmann,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .
[31] A. Dale,et al. Subregional neuroanatomical change as a biomarker for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.